Julie Zhen Qin Wu

Array ( [id] => 8370151 [patent_doc_number] => 20120219547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'Humanized Anti-TNFalpha Antibodies' [patent_app_type] => utility [patent_app_number] => 13/405144 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14181 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227779 [patent_doc_number] => 20120141978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'PRRSV GP5 BASED COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/371166 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 14998 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358623 [patent_doc_number] => 20120213781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Monovalent and Multivalent Multispecific Complexes and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/371379 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 90523 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371080 [patent_doc_number] => 20120220470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'DIAGNOSTIC METHOD FOR DETECTING CANCER BY MEASURING AMOUNT OF A CYTOKINE LIKE IL-6' [patent_app_type] => utility [patent_app_number] => 13/367132 [patent_app_country] => US [patent_app_date] => 2012-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4550 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393162 [patent_doc_number] => 20120231001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'PREVENTIVES/REMEDIES FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/367095 [patent_app_country] => US [patent_app_date] => 2012-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 56312 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107039 [patent_doc_number] => 20130280171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'METHOD TO OPTIMIZE THE TREATMENT OF PATIENTS WITH BIOLOGICAL DRUGS' [patent_app_type] => utility [patent_app_number] => 13/997069 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12239 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13997069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222489 [patent_doc_number] => 20140017264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'DOSAGE AND ADMINISTRATION OF BISPECIFIC SCFV CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/992460 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4388 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335115 [patent_doc_number] => 20120201820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'IMMUNOLOGICAL COMPOSITIONS AS CANCER THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 13/314841 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19603 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9068117 [patent_doc_number] => 20130259873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'METHODS FOR TREATING A TUMOR USING AN ANTIBODY THAT SPECIFICALLY BINDS HMW-MAA' [patent_app_type] => utility [patent_app_number] => 13/991136 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29249 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9502981 [patent_doc_number] => 08741291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Multifunctional antibody conjugates' [patent_app_type] => utility [patent_app_number] => 13/305354 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 42 [patent_no_of_words] => 48070 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13305354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452777 [patent_doc_number] => 20120263722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/288185 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 95845 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441491 [patent_doc_number] => 20120258108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/286707 [patent_app_country] => US [patent_app_date] => 2011-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 101160 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10580964 [patent_doc_number] => 09303083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Therapeutic agent for malignant tumors expressing MHC class II' [patent_app_type] => utility [patent_app_number] => 13/877844 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 9355 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10575180 [patent_doc_number] => 09297812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Means and methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E' [patent_app_type] => utility [patent_app_number] => 13/877035 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7010 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989269 [patent_doc_number] => 20130216550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'BREAST CANCER THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 13/825655 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14335 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784895 [patent_doc_number] => 20120046451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'ANTI-lgSF4 ANTIBODY AND UTILIZATION OF THE SAME' [patent_app_type] => utility [patent_app_number] => 13/238096 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 41797 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046451.pdf [firstpage_image] =>[orig_patent_app_number] => 13238096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153138 [patent_doc_number] => 08586039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Degraded TPO agonist antibody' [patent_app_type] => utility [patent_app_number] => 13/225999 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 61 [patent_no_of_words] => 28665 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13225999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11231010 [patent_doc_number] => 09458231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 13/819935 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 58 [patent_no_of_words] => 52840 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866008 [patent_doc_number] => 20130149711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'BARD1 Isoforms in Lung and Colorectal Cancer and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/817013 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21348 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617740 [patent_doc_number] => 20130023052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'MANIPULATOR SYSTEM AND MANIPULATION METHOD OF MICROMANIPULATION TARGET OBJECT' [patent_app_type] => utility [patent_app_number] => 13/637364 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 36581 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637364 [rel_patent_id] =>[rel_patent_doc_number] =>)